{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:54:50Z","timestamp":1781196890476,"version":"3.54.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Some muscular dystrophies may have a negative impact on fertility. A decreased ovarian reserve is 1 of the factors assumed to be involved in fertility impairment. AMH (anti-M\u00fcllerian hormone) is currently considered the best measure of ovarian reserve.<\/jats:p>\n            <jats:p>A total of 21 females with myotonic dystrophy type 1 (MD1), 25 females with myotonic dystrophy type 2 (MD2), 12 females with facioscapulohumeral muscular dystrophy (FSHD), 12 female carriers of Duchenne muscular dystrophy mutations (cDMD) and 86 age-matched healthy controls of reproductive age (range 18 \u2013 44 years) were included in this case control study. An enzymatically amplified 2-site immunoassay was used to measure serum AMH level.<\/jats:p>\n            <jats:p>The MD1 group shows a significant decrease of AMH values (median 0.7\u200ang\/mL; range 0 \u2013 4.9\u200ang\/mL) compared with age-matched healthy controls (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01). AMH levels were similar between patients and controls in terms of females with MD2 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.98), FSHD (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.55) and cDMD (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.60).<\/jats:p>\n            <jats:p>This study suggests decreased ovarian reserve in women with MD1, but not in MD2, FSHD and cDMD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020523","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T20:04:37Z","timestamp":1591214677000},"page":"e20523","source":"Crossref","is-referenced-by-count":5,"title":["Anti-M\u00fcllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies"],"prefix":"10.1097","volume":"99","author":[{"given":"Olesja","family":"Parmova","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Vlckova","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"CEITEC \u2013 Central European Institute of Technology, Masaryk University, Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hulova","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livie","family":"Mensova","sequence":"additional","affiliation":[{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"Department of Neurology, Second Faculty of Medicine, Charles University, Prague and University Hospital Motol, Prague"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Crha","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"Department of Obstetrics and Gynaecology, University Hospital Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Stradalova","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kralickova","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Jurikova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"Department of Paediatric Neurology, Masaryk University and University Hospital Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Podborska","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, University Hospital Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radim","family":"Mazanec","sequence":"additional","affiliation":[{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"Department of Paediatric Neurology, Masaryk University and University Hospital Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Dusek","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Jarkovsky","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Bednarik","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"CEITEC \u2013 Central European Institute of Technology, Masaryk University, Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Vohanka","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"CEITEC \u2013 Central European Institute of Technology, Masaryk University, Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Srotova","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Brno"},{"name":"Faculty of Medicine, Masaryk University, Brno"},{"name":"European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Czechia"},{"name":"CEITEC \u2013 Central European Institute of Technology, Masaryk University, Brno"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF03350681","article-title":"Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy","volume":"13","author":"Vazquez","year":"1990","journal-title":"J Endocrinol Invest"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.rbmo.2014.03.013","article-title":"Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy","volume":"29","author":"Srebnik","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"R3-20230915","first-page":"411","article-title":"An update on ovarian aging and ovarian reserve tests","volume":"9","author":"Amanvermez","year":"2016","journal-title":"Int J Fertil Steril"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of anti-M\u00fcllerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil Steril"},{"key":"R6-20230915","first-page":"527","article-title":"Qualitative and quantitative characterization of the follicular population in the adult human ovary [Caracteres qualitatifs et quantitatifs de la population folliculaire dans l\u2019ovaire humaine adulte]","volume":"12","author":"Gougeon","year":"1984","journal-title":"Contracept Fertil Sex"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1600-0412.2012.01471.x","article-title":"The role of anti-M\u00fcllerian hormone in female fertility and infertility - an overview","volume":"91","author":"Grynneru","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1210\/jc.2010-0930","article-title":"Serum levels of anti-m\u00fcllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients","volume":"95","author":"Hagen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum anti-m\u00fcllerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS One"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2009-0006","article-title":"Ovarian aging: mechanisms and clinical consequences","volume":"30","author":"Broekmans","year":"2009","journal-title":"Endocr Rev"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ptj\/72.2.115","article-title":"Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy","volume":"72","author":"Florence","year":"1992","journal-title":"Phys Ther"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2012.04.013","article-title":"Normal serum anti-M\u00fcllerian hormone levels in the general female population and the relationship with reproductive history","volume":"163","author":"La Marca","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin Biochem"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antim\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fneur.2018.00446","article-title":"Ovarian reserve in women with neuromyelitis optica spectrum disorder","volume":"9","author":"Th\u00f6ne","year":"2018","journal-title":"Front Neurol"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1212\/WNL.0000000000004843","article-title":"Ovarian aging is associated with gray matter volume and disability in women with MS","volume":"90","author":"Graves","year":"2018","journal-title":"Neurology"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-m\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.rbmo.2010.02.003","article-title":"Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype","volume":"20","author":"Dechanet","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humrep\/dei310","article-title":"Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?","volume":"21","author":"Feyereisen","year":"2006","journal-title":"Hum Reprod"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-007-9193-y","article-title":"Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I","volume":"25","author":"Sahu","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/humrep\/den105","article-title":"Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis","volume":"23","author":"Verpoest","year":"2008","journal-title":"Hum Reprod"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/2229-516X.96795","article-title":"Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility","volume":"2","author":"Verma","year":"2012","journal-title":"Int J Appl Basic Med Res"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10815-018-1141-5","article-title":"Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles","volume":"35","author":"Gracia","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1071\/RD17377","article-title":"Anti-M\u00fcllerian hormone receptor type 2 is expressed in gonadotrophs of postpubertal heifers to control gonadotrophin secretion","volume":"30","author":"Kereilwe","year":"2018","journal-title":"Reprod Fertil Dev"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1073\/pnas.1633592100","article-title":"Regulation of gonadotropin gene expression by Mullerian inhibiting substance","volume":"100","author":"B\u00e9d\u00e9carrats","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/cen.13967","article-title":"Has GnRH a direct role in AMH regulation?","volume":"90","author":"van Helden","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R32-20230915","first-page":"17","article-title":"Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency","volume":"pii:","author":"Takeshima","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:14:06Z","timestamp":1694823246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":32,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020523","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]}}}